Onasemnogen-Abeparvovec (Zolgensma®) – Spinal Muscle atrophia (SMA)

1. Characteristics

Start date 01.07.2020
Resolution 17.12.2020
INN Onasemnogen-Abeparvovec
Brand name Zolgensma®
Company AveXis
ATC code M09AX09
Therapeutic area Metabolic diseases METABOL ORPHAN
Reason for procedure New INN
Regulatory status Conditional Approval ATMP

10. Associated procedures

Resolution INN Brand name Indication Additional benefit
17.12.2020 Onasemnogen-AbeparvovecZolgensma®Spinale Muskelatrophie (SMA)


<< List of all resolutions